Skip to content

Clinical trials

Completed Ovarian Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Status: Completed Country / region: United States Clear all

875 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200022
200125
200221
200329
200433
200536
200642
200748
200837
200946
201040
201140
201223
201331
201434
201536
201639
201740
201841
201932
202020
202125
202216
202310
20245
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed875

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)69
Memorial Sloan Kettering Cancer Center60
Gynecologic Oncology Group43
M.D. Anderson Cancer Center26
Dana-Farber Cancer Institute19
AstraZeneca14
Fred Hutchinson Cancer Center14
Eli Lilly and Company13
Mayo Clinic13
Duke University12

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms875
Fallopian Tube Neoplasms249
Breast Neoplasms209
Carcinoma, Ovarian Epithelial182
Carcinoma, Non-Small-Cell Lung105
Neoplasms101
Colorectal Neoplasms99
Pancreatic Neoplasms89
Lung Neoplasms83
Uterine Cervical Neoplasms82

Trials

Showing 1 to 25 of 875. Each trial links to its page on Pharma Observatory.

775 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.